Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2025 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 33 % of short-term debt in 2025; threshold 65 %.
-
Shrinking team NBB
FTE fell two years in a row, from 2.8 to 0.
-
Busy address KBO
20 other companies have their registered office at the same address; threshold 10.
-
Legal situation KBO
Vrijwillige ontbinding – vereffening according to the CBE.
Financials
Financial year 2025
THERATOPIX PHARMA from Liège, company number BE0738446251, closed financial year 2025 with a result of € -18,947 after tax. For that financial year THERATOPIX PHARMA recorded revenue of € 49,054 and equity of € -129,765. Compared with financial year 2025, the result moved from € -436,443 to € -18,947. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 16, 2026.
€ -129,765
▼ € 18,947 vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -18,947
▲ 96 % less loss than in 2025
Profit after tax over the fiscal year.
€ 66,076
▲ 162% vs 2025
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -934,765.
People and assets in 2025
0
▼ 0.3 vs 2025
Average over the fiscal year, from the social balance sheet.
Debts at end 2025
€ 171,089
Loans from banks and other lenders, long and short.
€ 16,908
▼ 24% vs 2025
Supplier invoices still open on the last day of the fiscal year.
| 2023 | 2024 | 2025 | 2025 | Change 2025 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 84,622 | € 74,768 | € 20,376 | € 49,054 | ▲ 141% |
| Gross margin | € 58,991 | € -24,402 | € -90,676 | € -18,644 | ▲ € 72,032 |
| Profit after taxes | € -177,223 | € -205,565 | € -436,443 | € -18,947 | ▲ € 417,496 |
| Equity | € 824,640 | € 645,476 | € -110,818 | € -129,765 | ▼ € 18,947 |
| Total debts | € 406,509 | € 305,203 | € 257,245 | € 250,220 | ▼ 3% |
| Cash | € 521,852 | € 136,276 | € 25,174 | € 66,076 | ▲ 162% |
| Retained profit | € -273,811 | € -479,376 | € -915,818 | € -934,765 | ▼ € 18,947 |
| Bank debt | € 184,897 | € 185,208 | € 171,011 | € 171,089 | |
| Balance sheet total | € 1,231,149 | € 950,679 | € 146,427 | € 120,455 | ▼ 18% |
| Employees (FTE) | 3.1 | 2.8 | 0.3 | 0 | ▼ 0.3 |
Key figures of THERATOPIX PHARMA, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to THERATOPIX PHARMA?
What happened at THERATOPIX PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
THERATOPIX PHARMA is active according to the CBE. Legal situation: Vrijwillige ontbinding – vereffening.
- New annual accounts for financial year 2025: loss of € 436,443. filed late Source: NBB ↗
- New establishment in Liège. KBO
- Start of the company according to the CBE. KBO
In short
From € 177,224 loss in 2023 to € 18,947 loss in 2025.
On average € 19,000 of value added per employee in 2023.
Establishments
Establishment units
Physical locations of this company
Rue Louvrex 55-57
4000 Liège
Avenue Pré-Aily 10
4031 Liège
Active since 26 November 2019
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 20 companies are registered at this address.
All companies at this address →EXIMPA
LM GESTION
€ 402,903 gross margin · 2025
LASERFLASH
€ 1.7 million gross margin · 2023
Agence locale pour l'Emploi de Villers-le-Bouillet
SPARX INDUSTRIES
€ 19.7 million revenue · 2024
+15 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0738.446.251
- VAT number
- BE 0738.446.251
- Registered office
- Rue Louvrex 55-57, 4000 Liège
- Names & denominations
- THERATOPIX PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Vrijwillige ontbinding – vereffening
- Start date
- 26 November 2019
- Peppol
- Active · Active since 9 Apr 2026
- Activities · NACE
Vervaardiging van overige farmaceutische producten
Speur- en ontwikkelingswerk op biotechnologisch gebied
Vervaardiging van parfums en toiletartikelen
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten